[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100313349":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":17,"studyPopulation":18,"armGroups":13,"interventions":13,"overallOfficials":19,"centralContacts":23,"locations":13,"responsibleParty":29,"collaborators":13,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":13,"eligibilityCriteria":39,"healthyVolunteers":35,"sex":40,"minAge":13,"maxAge":13,"enrollmentInfo":41,"targetDuration":13,"studyType":44,"phases":13,"briefSummary":45,"conditions":46,"keywords":48,"overallStatus":50,"whyStopped":13,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":13},{"fullName":5,"class":6},"Peking University People's Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Detected NF-1 gene expression pattern in neurofibromatosis-asociated tumor","To examine the neurofibromatosis type 1(NF-1) gene expression of the patients with neurofibromatosis-associated tumor","3 years",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"FAMILY_BASED","PROSPECTIVE","Samples of blood and other stored material such as slides,frozen tissues or leftover diagnostic material.\n\nQuestionnaire information, including health history, growth and development, physical activity and family medical history information.\n\nIf patients have been diagnosed with a neurofibromatosis-associated tumor or another condition the investigator is interested in， the investigator will ask the patient to release medical record information relating to diagnosis and treatment of neurofibromatosis-associated tumor, other cancers, blood disorders, and similar conditions.","Asia",[20],{"name":21,"affiliation":5,"role":22},"Tingting Ren, phD","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":13,"email":28},"Kuisheng Liu, phD","CONTACT","+8601088324471","tumorcenter@163.com",{"type":30,"investigatorFullName":31,"investigatorTitle":32,"investigatorAffiliation":5,"oldNameTitle":13,"oldOrganization":13},"SPONSOR_INVESTIGATOR","Ren tingting","Musculoskeletal Tumor Center","100313349","the-neurofibromatosis-associated-tumor-biobank-100313349",false,"NCT03359304","The Neurofibromatosis-associated Tumor Biobank","Establishment of Neurofibromatosis-associated Tumours Biobank for Future Genomic-based Research Aiming at Improved Outcome Prediction","Inclusion Criteria:\n\nProband Inclusion criteria: A diagnosis or suspected diagnosis of neurofibromatosis-associated tumor Family member inclusion criteria: Biological parents and full biological siblings of a case diagnosed with neurofibromatosis-associated tumor\n\nExclusion Criteria:\n\nnon-asian","ALL",{"count":42,"type":43},300,"ESTIMATED","OBSERVATIONAL","Neurofibromatosis-associated Tumor is very rare bone tumor. The investigator set up the biobank to ensure every patient has the chance to participate in future research",[47],"Neurofibromatoses",[49],"bone tumor","NOT_YET_RECRUITING","2017-11-29",{"date":53,"type":54},"2017-12-02","ACTUAL",{"date":56,"type":43},"2018-03-01",{"date":58,"type":43},"2028-03-01",{"name":31,"class":6}]